ReviewJournal of hematology2022

Intravenous Fluid Administration and the Risk of Adverse Outcomes in Sickle Cell Disease Patients Hospitalized for Vaso-Occlusive Crisis.

Ademola S Ojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.